TOKAI PHARMACEUTICALS INC's ticker is TKAI and the CUSIP is 88907J107. A total of 49 filers reported holding TOKAI PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $13,000 | -78.7% | 15,755 | -74.7% | 0.00% | – |
| Q4 2016 | $61,000 | +84.8% | 62,327 | +192.1% | 0.00% | – |
| Q3 2016 | $33,000 | -76.9% | 21,337 | -17.8% | 0.00% | – |
| Q2 2016 | $143,000 | +31.2% | 25,968 | +33.3% | 0.00% | – |
| Q1 2016 | $109,000 | -25.3% | 19,486 | +16.7% | 0.00% | – |
| Q4 2015 | $146,000 | +14.1% | 16,702 | +35.0% | 0.00% | – |
| Q3 2015 | $128,000 | -21.0% | 12,368 | +1.4% | 0.00% | – |
| Q2 2015 | $162,000 | -4.1% | 12,193 | -18.4% | 0.00% | – |
| Q1 2015 | $169,000 | -68.1% | 14,935 | -58.4% | 0.00% | – |
| Q4 2014 | $530,000 | – | 35,935 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Owl Capital Management, LLC | 130,000 | $1,729,000 | 1.23% |
| Novo Holdings A/S | 1,238,252 | $16,469,000 | 1.18% |
| Perceptive Advisors | 485,338 | $6,455,000 | 0.39% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 740,978 | $9,855,000 | 0.38% |
| Tourbillon Capital Partners, L.P. | 517,000 | $6,876,000 | 0.15% |
| SABBY MANAGEMENT, LLC | 128,041 | $1,703,000 | 0.06% |
| Alyeska Investment Group, L.P. | 613,134 | $8,154,000 | 0.05% |
| ROPES WEALTH ADVISORS LLC | 6,000 | $80,000 | 0.04% |
| OPPENHEIMER & CO INC | 12,048 | $160,000 | 0.00% |
| FRANKLIN RESOURCES INC | 451,700 | $6,008,000 | 0.00% |